Nile Therapeutics, Inc.
Nile Therapeutics, Inc. (NLTX) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 123 transactions totaling $39.3M, demonstrating a bullish sentiment with $37.8M in net insider flow. The most recent transaction on Oct 5, 2023 involved a transaction of 57,049 shares valued at $0.
NLTX Insider Activity Summary
Who Is Buying NLTX Stock?
No significant insider buying has been recorded for NLTX in the recent period.
Who Is Selling NLTX Stock?
No significant insider selling has been recorded for NLTX in the recent period.
Is Nile Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NLTX is bullish with an Insider Alignment Score of 98/100 and a net flow of $37.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NLTX Frequently Asked Questions
Understanding NLTX Insider Activity
Insider trading at Nile Therapeutics, Inc. (NLTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading NLTX stock, having executed 123 transactions in the past 90 days. The most active insider is L.p. 667, (Executive), who has made 4 transactions totaling $25.3M.
Related Tools
Track Nile Therapeutics, Inc. Insider Activity
Get notified when executives and directors at NLTX file new Form 4 transactions